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HCV NS3 helicase exhibits activity toward DNA and RNA
substrates. TheDNAhelicase activity of NS3 has been proposed
to be optimal when multiple NS3 molecules are bound to the
same substrate molecule. NS3 catalyzes little or no measurable
DNAunwinding under single cycle conditions inwhich the con-
centration of substrate exceeds the concentration of enzyme by
5-fold. However, when NS3 (100 nM) is equimolar with the sub-
strate, a small burst amplitude of 8 nM is observed. The burst
amplitude increases as the enzyme concentration increases,
consistent with the idea that multiple molecules are needed for
optimal unwinding. Protein-protein interactions may facilitate
optimal activity, so the oligomeric properties of the enzyme
were investigated. Chemical cross-linking indicates that full-
length NS3 forms higher order oligomers much more readily
than the NS3 helicase domain. Dynamic light scattering indi-
cates that full-length NS3 exists as an oligomer, whereas NS3
helicase domain exists in a monomeric form in solution. Size
exclusion chromatography also indicates that full-length NS3
behaves as an oligomer in solution, whereas the NS3 helicase
domain behaves as amonomer.WhenNS3was passed through a
small pore filter capable of removing protein aggregates, greater
than 95% of the protein and the DNA unwinding activity was
removed from solution. In contrast, only 10% of NS3 helicase
domain and 20% of the associated DNA unwinding activity
was removed from solution after passage through the small pore
filter. The results indicate that the optimally active form of full-
length NS3 is part of an oligomeric species in vitro.
Helicases are molecular motors that catalyze unwinding of
double-stranded DNA or RNA by converting chemical energy
from ATP hydrolysis into mechanical energy for nucleic acid
strand separation. Helicases are required for virtually all cellu-
lar processes involving nucleic acids, including replication,
transcription, translation, repair, and recombination (1–4).
Several diseases characterized by premature aging and
increased incidence of cancer, including Bloom and Werner
syndromes, have been linked tomutations in helicase genes (5).
The quaternary structure of the active forms of helicases var-
ies considerably, with some requiring dimer or oligomer forma-
tion for strand separation activity and others functioning effi-
ciently as monomers. Bacteriophage T4 gp41 helicase, for
example, forms a hexameric structure that sequesters single-
stranded DNA by encircling it (6). Numerous other helicases
function as hexamers (7). Bacteriophage T4 Dda helicase is
active as a monomer (8) but unwinds DNA substrates more
efficiently under conditions that allow binding of multiple heli-
casemolecules per substratemolecule (9). Escherichia coli heli-
case TraI, also called helicase 1, can function as a robust, highly
processive helicase as a monomer (10). In order to understand
the mechanism by which helicases unwind duplex DNA, the
quaternary structure of the active species must be known.
More than 170 million people worldwide are infected with
the hepatitis C virus (HCV),4 predominantly through blood-
borne routes, such as contaminated blood/bloodproduct trans-
fusion and shared needle injection (11). The great majority
(85%) of patients develop chronic HCV infection characterized
by subclinical but persistent and progressive inflammation and
fibrosis of the liver, which can ultimately result in liver cirrho-
sis, hepatic failure, or hepatocellular carcinoma. HCV infection
has become the primary reason for liver transplants among
adults in Western countries (12). Moreover, current therapy is
inadequate in treating all patients afflicted with chronic HCV,
and an urgent medical need exists for an effective anti-HCV
agent (13). HCV contains a positive single-stranded RNA
genome that encodes a polyprotein of about 3010 amino acids
that is processed into structural (capsid, E1, E2, and p7) and
nonstructural (NS2, NS3, NS4a, NS4b, NS5a, and NS5b) pro-
teins by cellular and virus-encoded proteases (14). The NS3
protein is a 631-amino acid residue bifunctional enzyme with a
serine protease localized to the amino-terminal 180 residues
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and an NTPase-RNA helicase located in the carboxyl-terminal
451 residues (15) and is an attractive target for development of
an antiviral agent for HCV (16). NS3 helicase activity was iden-
tified; the associated protein was purified more than 10 years
ago (17), and the crystal structures of NS3 helicase domain
(NS3h) and full-length NS3 have been reported (18–20). How-
ever, the kinetic and chemical mechanisms for NS3h or full-
length NS3 remain an active area of investigation.
The full-length form of HCV NS3 is a bifunctional enzyme
consisting of protease and helicase domains. Both protease and
helicase activities are required for viral replication. NS3 has a
3-to-5 directional bias, unwinds both RNA and DNA, and
binds preferentially toU-rich or dT-rich nucleic acid substrates
(21–23). Some studies have focused on the activity of NS3h
(24), but NS3h appears to exist in solution as a monomer (25).
Several laboratories have published different conclusions
regarding the oligomeric state of full-length NS3 by using dif-
ferent approaches. Tackett et al. (26) have reported that bind-
ing ofmultipleNS3molecules to the same substratemolecule is
required for optimal unwinding of a 30-bp DNA duplex. Sere-
brov and Pyle (27) have reported that, based on comparison of
concentration-dependent processivity and binding data, the
active formofNS3 helicase is a dimerwith an 18-bp kinetic step
size. Dumont et al. (28) have reported that NS3 is active as a
monomer with an 11-bp kinetic step size in optical trap
unwinding experiments. Regarding the helicase domain, Levin
et al. (40) have reported a dominant negative effect of an
ATPase-deficient mutant on NS3h helicase unwinding, sug-
gesting that multiple molecules bound to the same substrate
can influence NS3h activity. The results for NS3h have been
interpreted in terms of functional cooperativity, which does not
rely on strong protein-protein interactions. In the functional
cooperativitymodel, NS3h is active as amonomer, but the pres-
ence of multiple molecules increases processivity. A similar
model has been put forth for Dda helicase (9, 30–32).
Frick et al. (33) compared the DNA and RNA unwinding
activities of NS3 and NS3h from HCV genotype 1a, leading to
the conclusion that the full-length protein unwinds RNAbetter
than the helicase domain alone. Hence, the presence of the
protease domain clearly influences the interaction of NS3 with
nucleic acid. The protease domain has also been reported to
facilitate dimerization of NS3 (34). In this work, we have inves-
tigated the quaternary form of NS3 by using chemical cross-
linking and biophysical approaches as well as DNA unwinding
measurements under pre-steady state conditions.
EXPERIMENTAL PROCEDURES
Materials—A high pressure liquid chromatography column
(Bio-Sil SEC 250-5 column) and gel filtration molecular weight
marker standard (molecular weight range 1,350–670,000)
were purchased from Bio-Rad. HEPES, -mercaptoethanol,
SDS, MOPS, Tris, NaCl, Na4EDTA, BSA, acrylamide, bisacryl-
amide, MgCl2, KOH, formamide, xylene cyanole, bromphenol
blue, urea, and glycerol were purchased from Fisher. BS3 was
purchased from Pierce. The Silver Stain Plus kit and 4–15%
Tris-Cl Ready Gels were purchased from Bio-Rad. Sephadex
G-25, PK/LDH, NADH, ATP, and PEP were from Sigma. Poly-
uridine was purchased from Amersham Biosciences. DNA oli-
gonucleotides were from Integrated DNA Technologies and
purified by preparative gel electrophoresis. [-32P]ATP was
purchased from PerkinElmer Life Sciences. T4 polynucleotide
kinase was obtained from New England Biolabs. Recombinant
full-length NS3 was derived from the HCV Con 1b replicon
consensus sequence and was purified as described (26). NS3h
was also derived from the HCV Con 1B replicon consensus
sequence and was purified as described (35).
Steady State DNA Unwinding—NS3 (100 nM) was prepared
in 25mMMOPS (pH 7.0), 10 mMNaCl, 0.1 mM EDTA (pH 8.0),
2 mM -mercaptoethanol, and 0.1 mg/ml BSA. DNA substrate
(15 nt/30 bp, the overhang strand radiolabeled with 32P) was
added to 100 nM, and the mixture was incubated at 37 °C for 5
min. The unwinding reaction was initiated by the addition of 5
mM ATP, 10 mM MgCl2 (unless otherwise specified), and a
30-fold excess of DNA trap to bind the displaced strand and
prevent reannealing to the radiolabeled product. After 1–10
min, a 10-l aliquot of the reactionmixture was transferred to a
centrifuge tube containing 200 mM EDTA, 0.7% SDS, 0.1%
bromphenol blue, 0.1% xylene cyanol, and 6% glycerol. The
double- and single-stranded DNAwere resolved via native 20%
polyacrylamide gel. The radiolabeled substrate and product
were detected using a PhosphorImager (Amersham Bio-
sciences). Quantitation was performed with ImageQuant soft-
ware (GE Healthcare), and the ratio of single- to double-
strandedDNAwas plotted as a function of time.Datawere fit to
a linear function using Kaleidagraph (Synergy Software, Read-
ing, PA).
Single Turnover and Pre-steady State DNAUnwinding—NS3
(500 nM) and DNA substrate (2 nM 15 nt/30 bp, the longer
strand radiolabeled with 32P) were prepared in 25 mM MOPS
(pH 7.0), 10mMNaCl, 0.1mM EDTA (pH 8.0), 2mM -mercap-
toethanol, and 0.1 mg/ml BSA. Reaction components were
incubated at 37 °C using a circulating water bath. The unwind-
ing reactionwas initiated by the rapid addition of 5mMATP, 10
mM MgCl2 (unless otherwise specified), 30-fold excess DNA
trap, and 10-fold excess polyuridine protein trap using an
RQF-3 Rapid Quench Flow instrument (KinTek Corp., Austin,
TX). The reaction was quenched after 0.1–10 s by adding 200
mM EDTA and 0.7% SDS. Bromphenol blue (0.1%), 0.1% xylene
cyanol, and 6%glycerolwere added to each, and the double- and
single-stranded DNA were resolved via native 20% polyacryl-
amide gel. The radiolabeled substrate and product were
detected using a PhosphorImager (Amersham Biosciences).
Quantitation was performed with ImageQuant software
(Amersham Biosciences), and the ratio of single- to double-
strandedDNAwas plotted as a function of time.Datawere fit to
a two-step mechanism for DNA unwinding as described (26).
Chemical Cross-linking—Chemical cross-linking was carried
out by incubating NS3/NS3h (final concentration is 2 M) in a
buffer containing 50 mM MOPS K (pH 7.0), 10 mM NaCl at
37 °C. After 30 min, BS3 (2 mM in H2O) was added to a final
concentration of 500M. Aliquots of the reactionmixture were
removed at various time points, quenched by adding 1M glycine
(pH 8.0) and protein sample buffer (62.5 mM Tris-Cl (pH 6.8),
0.45% SDS, 10% glycerol, 5% -mercaptoethanol, and 0.004%
bromphenol blue), incubated at 100 °C for 5 min, analyzed by
SDS-PAGE (4–15% gradient gel), and visualized by silver stain-
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ing. Another chemical cross-linkingwas carried out by incubat-
ing NS3 (final concentration is 2 M) in the same buffer as
above along with poly(dT) (varying concentrations) at 37 °C.
After 30 min, BS3 (2 mM in H2O) was added to a final concen-
tration of 500M.After 20min, the reactionwas quenched. The
reaction was analyzed by SDS-PAGE (4–15% gradient), and
protein was visualized by silver staining.
Dynamic Light Scattering—The hydrodynamic radii of wild
type NS3 and NS3h were measured by dynamic light scattering
using a DynaPro MS/X dynamic light scattering instrument
from Protein Solutions, Inc. NS3was used at a concentration of
0.5 mg/ml, whereas NS3h was used at 1.0 mg/ml. Additionally,
50 l of each sample was filtered through a 0.22-m filter. The
quartz cell was regulated at 20 °C. Measurements were made at
a fixed angle of 90° using an incident laser beam of wavelength
830 nm. Twenty measurements were made with an acquisition
time of 10 s for each measurement. The data were analyzed
using the graphical size analysis software, Dynamics, provided
with the instrument.
High Pressure Gel Filtration Chromatography—Gel filtration
was carried out at room temperature using a Bio-Sil SEC 250-5
column (300  7.8 mm). Elution was monitored by measuring
absorbance at 280 nm. The flow rate was 1 ml/min. 20 l of
molecular weight standard mixtures were injected into the col-
umnwith running buffer containing 100mMK2HPO4, KH2PO4
(pH 7.0), and 10 mM or 150 mM NaCl. NS3 or NS3h was incu-
bated for 5min in running buffer before being injected onto the
column.
Protein Filtration through Small Pore Filters—Whatman
Anotop disposable syringe filters (ThermoFisher) were used to
remove oligomeric protein from solution forNS3 andNS3h.An
aliquot of protein (100 l) was allowed to thaw on ice and then
passed through the filter (0.1 or 0.02 m). Equal volumes of
filtered or unfiltered protein were then assay for protein con-
centration by using a modified Bradford assay (Pierce).
ATPase Assays—Identical volumes of filtered or unfiltered
NS3 or NS3h were examined for ATPase activity by using the
phosphoenolpyruvate kinase/lactate dehydrogenase-coupled
assay (36). The specific activity for ATP hydrolysis was calcu-
lated, assuming that the entire enzyme concentration passed
through the filter. NS3 or NS3h was incubated with 5 mM ATP
in 25 mM MOPS (pH 7.0), 10 mM MgCl2, 10 mM NaCl, 0.1
mg/ml BSA, 4 mM phosphoenolpyruvate, 10 units/ml pyruvate
kinase, 15 units/ml lactate dehydrogenase, and 0.9 mM NADH.
ATP hydrolysis rates were determined by measuring the con-
version ofNADH toNAD at 380 nm in the presence of 100M
polyuridine. Hydrolysis rates were calculated using an extinc-
tion coefficient of 1,210 M1 cm1 for NADH.
RESULTS
Kinetic Simulations of DNA Unwinding under Pre-steady
State Conditions—We have previously shown that the Dda and
TraI helicases can unwind DNA substrates as monomeric
enzymes (8, 10). We used a functional approach in which the
active form of these two enzymes was determined by using an
active site titration. DNA unwinding experiments were per-
formed under pre-steady state conditions in which the sub-
strate concentration exceeded the enzyme concentration.
Under pre-steady state conditions, the quantity of product in
the first cycle of DNA unwinding is reflective of the quantity of
active enzyme and is referred to as the burst amplitude of the
reaction. For Dda and TraI, the burst amplitude was similar to
the concentration of enzyme, indicating that each helicase was
capable of unwinding DNA in a monomeric form. Dda is only
capable of unwinding short duplexes (low processivity),
whereas TraI appears to be capable of unwinding much longer
duplexes (high processivity).
A kineticmodel for a two-step process for unwinding a 30-bp
DNA substrate is shown in Fig. 1A. The model was designed to
simulate DNA unwinding by NS3 helicase. Only two kinetic
steps are required for unwinding a 30-bp substrate, because
NS3 has a very large kinetic step size of 18 bp (27); however,
smaller, physical steps occur during the slow, rate-limiting
kinetic step (28, 37). The kinetic scheme allows the enzyme to
dissociate from the substrate according to rate constant kd, or
unwind the substrate to form a partially unwound intermedi-
ate, ES*. The enzyme substrate intermediate can dissociate or
undergo a second unwinding step to produce product. For the
kinetic simulation, ku was set at 2.0 s1, which was the fastest
rate constant that was measured for DNA unwinding in a pre-
vious report (26). The concentration of enzyme substrate com-
plex (ES) was set at 50 nM, based on preincubation of 50 nM
enzyme with excess concentration of substrate (250 nM). The
dissociation rate constant was initially set at 0 s1, which sim-
ulates an infinitely processive helicase. If NS3 is assumed to
function as a monomer, then the kinetic simulation shows
clearly that 50 nM NS3 should produce 50 nM ssDNA product
under these conditions (Fig. 1B, filled squares). As the dissoci-
ation constant increases from0 to 8 s1, the quantity of product
declines. Hence, a helicase can produce less than the expected
burst amplitude due to low processivity.
NS3 can unwind most of the 30-bp substrate (15 nt/30 bp)
under single turnover conditions in the presence of a large
excess of enzyme concentration over substrate concentration
(Fig. 1C) (26). The fact that most of the substrate (80%) was
converted to product in the presence of excess enzyme indi-
cates that NS3 can be relatively processive, but it says nothing
about the form of the protein that is responsible for unwinding
the substrate, because the enzyme is in excess of the substrate.
When NS3 (50 nM) was incubated with excess substrate (250
nM), no product was observed (Fig. 1D, filled circles). If mono-
meric NS3 exhibited the level of DNA unwinding activity sug-
gested by the data in Fig. 1C, then 40 nM ssDNAproduct should
be observed, because 80% of the bound enzyme would be
expected to unwind the DNA. However, little or no product is
actually observed under these conditions. If the protein trap is
removed, then some product is observed over time (open circles
in Fig. 1D), indicating that NS3 is somewhat active under these
conditions. We conclude that a monomeric form of NS3 is not
responsible for rapid, processive DNA unwinding as observed
in Fig. 1C.
NS3-catalyzedDNAUnwinding Is Fast andRelatively Proces-
sive When Enzyme Concentration Is in Excess of Substrate
Concentration—It is possible that the lack of a highly active
monomeric form of NS3 is due to less than optimal reaction
conditions. For example, binding of NS3 to DNA is sensitive to
NS3 Exists as an Oligomer in Vitro
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the concentration of salt in the reaction mixture. The condi-
tions for conducting DNA unwinding may influence the rate
and amplitude of product formation when the concentration of
NS3 is in excess of the substrate.We examined several different
concentrations ofATP andMgCl2.NS3 (500 nM)was incubated
with the 15-nt/30-bp substrate (2 nM), and the reaction was
initiated upon the addition of ATP. Similar rates and ampli-
tudes for product formation were observed regardless of
whether the concentration ofATPwas equal to, greater than, or
less than the concentration ofMgCl2 (supplemental Fig. 1). The
addition of varying concentrations of detergent reduced the
rate slightly but did not change the amplitude for unwinding
(supplemental Table 1). Under all conditions studied, the frac-
tion of substrate converted to product and the rate of unwind-
ing were similar. Hence, the species of NS3 responsible for
unwinding the 30 base pairs of DNAunder conditions of excess
enzyme is a relatively fast and processive form of the enzyme
under a variety of conditions.
NS3-catalyzed DNA Unwinding Exhibits a Non-zero Inter-
cept When Substrate Is in Excess of Enzyme—We have already
shown that no burst amplitude is observed when the substrate
concentration exceeds the enzyme concentration by 5-fold
(Fig. 1C). If NS3 forms an active species, such as a dimer, then it
might be possible to observe a burst amplitude for DNA
unwinding when the enzyme concentration is equal to or in
slight excess of the substrate concentration. The dissociation
constant for the 15-nt/30-bp DNA substrate was previously
reported to be 2.7 nM when measured by gel shift assay and 5.2
nM when measured by fluorescence polarization (26). We con-
ducted DNA unwinding experiments at 100 nM DNA and 100
nMNS3 in order that enzyme and substratewould bewell above
the dissociation constant. NS3 was incubated with the 15-nt/
30-bp DNA substrate followed by initiation of unwinding by
mixing with ATP and MgCl2. Varying the concentration of
ATP (Fig. 2A) and MgCl2 (Fig. 2B) and the addition of varying
concentrations of detergent (Tween 20) had little effect on the
steady state rate of unwinding. The observed rates for product
formation ranged from 2.0 to 4.2 nM/min. These data all exhibit
a non-zero intercept at the y axis, indicating a small burst
amplitude, which ranged from8 to 16 nM. Themagnitude of the
burst amplitude is much lower than expected for a monomeric
FIGURE 1. Kinetic simulation for pre-steady state DNA unwinding by NS3.
A, kinetic scheme describing DNA unwinding by NS3. Two steps are needed
to unwind a 30-bp DNA substrate. NS3 can dissociate from substrate at each
step. A trapping strand is included in the simulation to prevent enzyme from
rebinding to substrate. B, kinetic simulation for pre-steady state unwinding of
250 nM 15-nt/30-bp partial duplex DNA by 50 nM NS3 in the presence of a
protein trap (75 M nt polyuridine). Shown are results from kinetic simula-
tions in which the unwinding rate constant, ku, was held constant at 2.0 s
1,
whereas the dissociation rate constant, kd, was set at 0 s
1 (f), 0.4 s1 (F), 1.0
s1 (E), 2.0 s1 (Œ), 4.0 s1 (‚), and 8.0 s1 (). C, single turnover conditions
were used to measure DNA unwinding of a substrate containing 15 nt of
ssDNA overhang and 30 bp (15 nt/30 bp). NS3 (500 nM) was incubated with
the DNA substrate, and the unwinding reaction was initiated upon rapid mix-
ing with ATP (5 mM) and MgCl2 (10 mM). A protein trap (polyuridine, 75 M nt)
was introduced along with the ATP. Reactions were quenched with EDTA (200
mM), and products were examined by native gel electrophoresis. The data
were fit to a two-step mechanism for unwinding using the program Scientist,
resulting in an observed unwinding rate (ku) of 1.03  0.1 s
1 and an ampli-
tude of 0.8  0.1 nM. D, DNA unwinding was conducted under the same
conditions as in the kinetic simulation. NS3 (50 nM) was incubated with a
15-nt/30-bp DNA substrate (250 nM), followed by initiation of the unwinding
reaction by the addition of ATP (5 mM) and MgCl2 (10 mM). Product formation
was measured in the presence (F) or absence (E) of a protein trap (75 M nt
polyuridine).
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or dimeric enzyme. If a monomer or dimer is the only active
species and is the primary form of NS3 in solution, then amuch
higher burst amplitude would be observed based on the rate
and processivity measured under conditions of excess enzyme
(Fig. 1C). One possible explanation for the low burst amplitude is
that the most active form of NS3 in vitro is an oligomer, thereby
assuring that multiple molecules of NS3 are bound to each DNA
substrate.This conclusiondoesnot exclude thepossibility that the
monomeric or dimeric forms are completely inactive.
“Burst Kinetics” Are Observed When NS3 Is Similar to the
Substrate Concentration—To further examine the apparent
burst amplitudes indicated in Fig. 2, rapid mixing experiments
were performed with 100 nM substrate and increasing concen-
trations of NS3. The results indicate that rapid unwinding does
occur under these conditions, resulting in a low butmeasurable
quantity of ssDNA. NS3 (100 nM) unwound the DNA (100 nM)
with a burst amplitude of 7.5 nM (Fig. 3 and Table 1), consist-
ent with the results from Fig. 2. Increasing NS3 concentration
up to 400 nM resulted in a linear increase in the burst amplitude
(Fig. 3B). The linear increase in amplitude as a function of NS3
FIGURE 2. DNA unwinding under varying conditions with equimolar
enzyme and substrate concentrations. NS3 (100 nM) was incubated with
DNA (100 nM, 15-nt/30-bp substrate), followed by the addition of ATP and
Mg2 to start the reaction. DNA unwinding was conducted under the follow-
ing conditions. A, in the presence of 1 mM (F), 2.5 mM (f), 5 mM (), and 7.5
mM (Œ) ATP with 10 mM MgCl2. B, in the presence of 1 mM (Œ), 2.5 mM (), 5
mM (f), and 10 mM (F) MgCl2 with 5 mM ATP and 1 mM MgCl2 with 1 mM ATP
(‚). C, in the presence of 0% (F), 0.01% (f), and 0.1% (Œ) Tween 20 with 5 mM
ATP and 10 mM MgCl2. Data were fit to a linear function.
FIGURE 3. DNA unwinding under pre-steady state conditions reveals a
low burst amplitude. A, the 15-nt/30-bp substrate (100 nM) was incubated
with 50 nM (E), 100 nM (Œ), 200 nM (‚), 300 nM (F), or 400 nM () NS3 prior to
initiation of DNA unwinding upon mixing with ATP. The observed forward
rate constants and amplitudes for product formation were determined by
fitting the data to a two-step mechanism and are shown in Table 1. B, NS3
concentrations are plotted versus amplitudes from the data in A. The data
were fit to a linear function resulting in a slope of 8.3.
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concentration indicates that the enzyme species that unwinds
the substrate has similar activity over the concentration range
being examined (50–400 nM). It might be expected that an
oligomeric form of NS3 would exhibit a sigmoidal increase in
activity with increasing enzyme concentration if an oligomer is
the optimally active species. However, it is possible that some
oligomerization occurs at NS3 concentrations lower than 50
nM. We turned to biochemical and biophysical approaches to
investigate the oligomeric nature of NS3.
The question arises as to whether the DNA unwinding activ-
ity observed in vitro relates directly to RNA unwinding activity.
Several quantitative, ensemble approaches have been reported
for studying RNA unwinding in which the NS3 concentration
greatly exceeds the substrate concentration (27, 38, 39). Our
results with NS3 indicate that little or no RNA unwinding
occurs when the enzyme concentration is similar to that of the
substrate concentration, although fast and relatively processive
unwinding occurs when the enzyme concentration greatly
exceeds the substrate concentration (supplemental Fig. 3). This
trend is the same as that observed for NS3-catalyzed DNA
unwinding; therefore, it is reasonable at this time to conclude
that an oligomeric form of NS3 is responsible for optimal RNA
unwinding under these conditions.
Chemical Cross-linking of NS3 Reveals Oligomeric Structures—
Chemical cross-linking has been used previously to evaluate the
ability of NS3h to form oligomeric structures, and higher order
species were observed (40). To directly compare NS3 cross-
linking with that of NS3h, both proteins were treated with the
homo-bifunctional cross-linker BS3 under identical conditions.
NS3h can be cross-linked, which is consistent with previous
observations (40), although dimers were primarily observed
under conditions used here (Fig. 4A). NS3 forms larger cross-
linked species and in greater quantity than NS3h under identi-
cal conditions (Fig. 4B). During longer incubation times, most
of the NS3 cross-linked structures do not migrate into the gel.
This indicates thatNS3may formoligomeric structures in solu-
tion much more readily that NS3h.
Dynamic Light Scattering Supports an Oligomeric Form of
NS3 but aMonomeric Form of NS3h—Dynamic light scattering
is an alternative way to determine size distributions of particles
in solution. Fig. 5, A and B, represent the size distribution his-
tograms of NS3h andNS3, respectively, obtained in buffer con-
ditions that mimic those used in the DNA unwinding assay (10
mM NaCl, 50 mM MOPS-K, pH 7.0). NS3h exhibits a mono-
modal, monodisperse profile with a hydrodynamic radius of
3.9 nm, as measured by dynamic light scattering. NS3 is
shown to exist as a monomodal, polydisperse protein with a
hydrodynamic radius of29.4 nm (Fig. 5B). These results indi-
cate that NS3 exists as an oligomeric species made up of 7–10
molecules under these conditions.
Size Exclusion Chromatography Indicates That NS3 Exists as
an Oligomer in Solution—Several attempts to examine the oli-
gomeric form of NS3 by sedimentation equilibrium and sedi-
mentation velocity methods failed due to precipitation of NS3.
We turned to size exclusion chromatography to further analyze
the oligomeric form of NS3. Full-length NS3 eluted from the
column near the void volume, which corresponds to a molecu-
lar size equal to or greater than700 kDa (Fig. 6A). In contrast,
NS3h elutes from the column at the expected position for a
monomeric protein of 50 kDa. Interestingly, the same quantity
of each protein was injected on the column, but the peak for
NS3h was much larger than that for NS3. This result suggests
that some NS3 may not elute from the column. NS3 and NS3h
were then incubated with higher salt concentration (150 mM
NaCl), resulting in similar retention times for each protein as
observed under lower salt conditions, but the quantity of NS3
eluting from the column was increased when compared with
the peak from NS3h (Fig. 6B). Similar results were observed
FIGURE 4. Time dependence of NS3 cross-linking using BS3 indicates oli-
gomerization. A, silver stain of a SDS-PAGE (4 –15% gradient) gel showing
time dependence of cross-linking of NS3h. The experiment was carried out by
adding 500 M BS3 to a solution containing 2 M NS3h in 50 mM MOPS-K (pH
7.0) and 10 mM NaCl, which had incubated at 37 °C for 30 min. Aliquots of the
reaction mixture were removed at various times and quenched by adding 1 M
glycine (pH 8.0). B, silver staining of a SDS-PAGE (4 –15% gradient) gel show-
ing time dependence of cross-linking of NS3 under the same condition as
above for NS3h.
TABLE 1
Kinetic parameters for DNA unwinding under presteady state
conditions
DNA (100 nM, 15-nt/30-bp partial duplex) was incubated with NS3 (50–400 nM),
followed by rapid mixing with ATP and Mg2 at 37 °C. Data were fit to a two-step
unwinding mechanism to obtain the observed forward rate constant for each step,
ku, and the amplitude for the reaction (26).
NS3 ku Amplitude
nM s1 nM
50 2.7  0.5 7.8  0.5
100 1.1  0.2 14  1
200 1.4  0.3 23  2
300 1.0  0.1 40  1
400 1.1  0.1 48  3
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when NS3 was examined in the presence of an oligonucleotide,
indicating that the oligomeric structure was similar in the pres-
ence and absence of ssDNA (supplemental Fig. 2).We conclude
that NS3 can exist as an oligomeric species in solution and that
higher salt concentrations somewhat reduce protein-protein
interactions.
Passage ofNS3 through Small Pore Filters Removes theMajor-
ity of the Protein and the Enzyme Activity—Small pore filters
can remove large, oligomeric protein complexes from solution.
To determine whether the enzymatic activity of NS3 was asso-
ciated with the oligomeric structures, NS3 and NS3h were
passed through 0.1- and 0.02-m filters (low protein binding
Anotop syringe filter; Whatman) followed by measurements of
protein concentration and enzyme activity. A modified Brad-
ford assay usingCoomassie Brilliant Blue 250was used tomeas-
ure protein concentration. When comparing filtered NS3 ver-
sus unfiltered NS3, greater than 90% of NS3 was removed upon
passage through the 0.02-m filter, whereas lesser amounts
were removed from the 0.1-m filters (Fig. 7A). The ATPase
activity of NS3 was measured in the presence of 100 M poly-
uridine. The reduction in activity correlated strongly with the
reduction in protein concentration (Fig. 7B). It is possible that
NS3 adheres to the membrane filter, so NS3h was also exam-
ined. Only 25% of protein was removed when NS3h was
passed through the 0.02-m filter, and the reduction in NS3h
ATPase activity correlated with the reduction in protein con-
centration (Fig. 7, A and B).
The DNA unwinding activity of filtered versus unfiltered
enzyme was also examined. No product formation was
observed when examining NS3-catalyzed DNA unwinding of
filtered protein (Fig. 7C), indicating that the activity resides in
the filtered protein. In contrast, most of the DNA unwinding
activity was recovered in the case of filtered NS3h when com-
pared with unfiltered NS3h (Fig. 7D). These results support the
conclusion that NS3 exists in an oligomeric form under these
conditions and that its enzymatic activity resides within this
oligomeric form.
FIGURE 5. Dynamic light scattering of NS3 supports an oligomeric struc-
ture. A, the size distribution histograms of NS3h as determined from dynamic
light scattering. NS3h is shown to exist as a monomodal, monodisperse pro-
tein with a hydrodynamic radius of 3.9 nm. B, the size distribution histo-
grams of NS3 as determined from dynamic light scattering. NS3 is shown to
exist as a monomodal, polydisperse protein with a hydrodynamic radius of
29.4 nm.
FIGURE 6. Size exclusion chromatography of NS3 supports an oligomeric
structure. A, NS3 and NS3h (450 pmol) were injected onto a Bio-Sil SEC 250-5
column (Bio-Rad) in buffer containing 0.1 M potassium phosphate, pH 7.0, 10
mM NaCl. The standard curve (closed red diamonds) was prepared as
described under “Experimental Procedures.” The red diamonds represent the
elution times for standard proteins: thyroglobulin (670,000 Da), IgG (158,000
Da), ovalbumin (44,000 Da), and myoglobin (17,000 Da). NS3 (blue line) eluted
from the column near the void volume, and NS3h (black line) eluted as a
monomer of 50 kDa. B, NS3 and NS3h were analyzed as described in A except
that the NaCl concentration was raised to 150 mM.
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DISCUSSION
Helicases coordinate ATP hydrolysis with movement along
nucleic acid and concomitant unwinding of DNA (3). A mech-
anism for coupling ATP hydrolysis to molecular motion has
been described for PcrAhelicase (fromSF1) and is supported by
extensive x-ray crystallography (41) and biochemical results
(42). ATP binding and hydrolysis is proposed to drive PcrA
through multiple conformational changes that allow the
enzyme to move in an “inch-worm” fashion along ssDNA. A
relatedmechanismhas beendescribed forNS3h, based on x-ray
crystallographic analysis (24). These inchworm mechanisms
do not require a helicase to oligomerize in order to function.
Some helicases clearly oligomerize into hexameric struc-
tures to exert their function (7, 43). However, evidence sug-
gests that for some SF1 helicases,
optimal DNA unwinding activity
occurs in the presence of a dimeric
form of the enzyme. In the case of
UvrD and Rep helicases, optimal
DNA unwinding in vitro occurs
when these enzymes form dimeric
(44) or oligomeric structures (45),
although UvrD monomers readily
translocate on ssDNA (46). It is pos-
sible that some factor that stimu-
lates DNA unwinding in vivo is sim-
ply not present in vitro, which may
contribute to the need for oligomer-
ization in vitro.
Previous work from other labora-
tories has indicated that NS3 exhib-
its intramolecular protein-protein
interactions. A yeast two-hybrid
assay and results from gel filtration
experiments by Khu et al. (34) indi-
cate that dimerization may be
important for helicase activity.
Analysis of biochemical activity has
also led to the conclusion that a
dimeric form of NS3 is active (27).
We employed biochemical and bio-
physical methods to investigate the
oligomeric state of theNS3 helicase.
The unwinding results are revealing
when the amplitudes for product
formation are considered under dif-
fering reaction conditions. When
the enzyme is in great excess over
substrate (500 nM NS3, 2 nM DNA
substrate), most of the substrate is
quickly converted to product, indi-
cating a relatively processive formof
the NS3 (Fig. 1C). However, when
the DNA substrate is in great excess
of the enzyme (50 nM NS3, 250 nM
DNA substrate), no measurable
product is formed under single
turnover conditions (Fig. 1D).
These data strongly indicate that themonomeric formofNS3 is
not responsible for the fast and relatively processive unwinding
observed in Fig. 1C.
A recent report indicates that the activity of NS3h can be
stimulated substantially by inclusion of a single-stranded bind-
ing protein (SSB) in the reaction mixture and that NS3–4A
unwinding activity is also stimulated but to a lesser extent (47).
We testedE. coli SSB to determinewhether the burst amplitude
of NS3 is enhanced under pre-steady state conditions. The
amplitude for product formation was increased by less than
2-fold, but the rate constant for DNA unwinding was increased
by 7-fold (supplemental Fig. 4). These results do not change
our conclusion that NS3 functions optimally as an oligomer,
but the role played by multiple molecules of NS3 during DNA
FIGURE 7. Filtration through small pore filters removes the majority of NS3 but not NS3h. A, NS3 or NS3h
was passed through a syringe tip filter of the indicated pore size, and the resulting filtrate was assayed for
protein concentration by using a modified Bradford assay (A) and ATPase activity (B). NS3 concentration was
0.63 mg/ml prior to filtration. NS3 concentration was reduced to 0.06 and 0.03 mg/ml after passage through
the 0.1- and 0.02-m filters, respectively. NS3h concentration was 0.36 mg/ml prior to filtration. NS3h concen-
tration was reduced to 0.35 and 0.32 mg/ml after passage through the 0.1- and 0.02-m filters, respectively.
B, polyuridine-stimulated ATPase activity was measured for NS3 and NS3h before and after filtration. NS3 (or
NS3h) was incubated with polyuridine (100 M), and measurements were made as described under “Experi-
mental Procedures.” NS3-specific activity was 24  1 s1 prior to filtration. NS3 activity was 1.9  0.2 s1 and
0 after passage through the 0.1- and 0.02-m filters, respectively. NS3h-specific activity was 49  3 s1 prior
to filtration. NS3h-specific activity was 34  2 and 33  2 s1 after passage through the 0.1- and 0.02-m filters,
respectively. C, NS3 was passed through a 0.02-m filter, and the resulting solution was analyzed for DNA
unwinding activity. No unwinding was observed (). An identical volume of unfiltered NS3 (250 nM) was
incubated with the DNA substrate (15-nt/30-bp substrate, 2 nM), and the unwinding reaction was initiated
upon rapid mixing with ATP (5 mM) and MgCl2 (10 mM). A protein trap (polyuridine, 75 M nt) was introduced
along with the ATP. Reactions were quenched with EDTA (200 mM), and products were examined by native gel
electrophoresis. Data were fit to a two-step mechanism, resulting in an observed unwinding rate of 1.4  0.1
s1 and amplitude of 0.66  0.05 nM. D, NS3h was passed through a 0.02-m filter, and the resulting solution
was analyzed for DNA unwinding activity (Œ). An identical volume of unfiltered NS3h (1.0 M) was analyzed for
DNA unwinding activity (E). A double-push method was used for these experiments, because NS3h catalyzes
spontaneous unwinding of the 15-nt/30-bp substrate in the absence of ATP at 37 °C. The first push mixed NS3h
with the DNA, followed by a brief incubation period of 10 s. The second push rapidly mixed the enzyme with
ATP (5 mM) and MgCl2 (10 mM). A protein trap (polyuridine, 75 M nt) was introduced along with the ATP.
Reactions were quenched with EDTA placed in the receiving vial (200 mM), and products were examined by
native gel electrophoresis. Data for NS3h were fit to a four-step mechanism, resulting in an observed unwind-
ing rate constant of 2.6  0.2 s1 and amplitude of 0.14  0.01 nM for the unfiltered enzyme and observed rate
constant of 2.3  0.2 s1 and amplitude of 0.11  0.01 nM for the filtered enzyme.
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unwinding can be compensated in part by the presence of SSB.
The mechanism proposed by Rajagopal and Patel is that SSB
serves to stabilize the helicase at the unwinding junction and
prevent its dissociation. Such a mechanism could also apply to
an oligomeric form of NS3.
A kinetic model termed functional cooperativity was previ-
ously described for NS3h in which multiple enzyme molecules
acting on the same substrate molecule are required for optimal
DNA unwinding (29). The full-length NS3 and the helicase
domain (NS3h) share the property whereby fast and processive
DNA unwinding is observed only when the enzyme concentra-
tion greatly exceeds the substrate concentration. The DNA
unwinding results in Figs. 1–3 can be explained by the func-
tional cooperativitymodel, by amodel inwhichNS3 exists in an
oligomeric form, or by a combination of these two phenomena.
The biophysical data reported here support an oligomeric
form of NS3 as the species that is responsible for optimal DNA
unwinding. Dynamic light scattering reveals thatNS3h exists as
a monomeric species, whereas NS3 forms oligomeric species
(Fig. 5), consistent with the kinetics data. The size exclusion
chromatography experiments show that oligomeric species of
NS3 form readily (Fig. 6). Small pore filters that are able to
remove large oligomeric proteins were used to investigate
whether the active form of NS3 was found within the oligo-
meric structures. Filtration of NS3 andNS3h through the small
pore filters shows that the active form of NS3 is retained by the
0.02-m filter, whereas the majority of protein and enzyme
activity of NS3h readily passes through the filter (Fig. 7). The
fact thatNS3 behaves quite differently thanNS3h indicates that
the NS3 protease domain may modulate the protein-protein
interactions. One report provides evidence that the minimal
region required for this interaction maps to a specific subdo-
main of 174 amino acids in the N terminus of the helicase
region (34).
The overall conclusion from this work is that NS3 oligomer-
izes in solution at concentrations that are typically utilized in
ensemble biochemical experiments and that the oligomer con-
tains the optimally active form of NS3. Oligomerization of NS3
may be due to nonspecific protein-protein interactions that
occur due to the absence of other proteins that are known to
interact withNS3. NS3 andHCVpolymerase (NS5B) have been
shown to interact and influence each other’s activity in vitro
(48–52). If the oligomeric form of NS3 is heterogeneous, then
some quantity of protein might be inaccessible to the DNA
substrate. For example, an oligomeric structure made of 7–10
molecules of NS3might contain somemolecules that are prop-
erly oriented for DNA unwinding activity, whereas other mol-
ecules might be buried within the nonstructured oligomer. We
are currently investigating the nature of the oligomer, including
its dependence on solution conditions and the presence of
other HCV proteins. Recent studies indicate that NS3 concen-
tration greatly exceeds the concentration of HCV RNA in the
cell (53). Therefore, it is possible that each strand of HCV RNA
is acted on by many molecules of NS3.
Based on the kinetic simulation and experimental results in
Fig. 1, it is clear that NS3 monomers have much lower activity
than the optimal form of NS3 in vitro. The fact that the unex-
pectedly lowburst amplitude is observed under pre-steady state
conditions can be explained if the monomer is far less proces-
sive than the optimally active form or if the monomer has a
much lower rate of unwinding. A small degree of DNAunwind-
ing is observed in the presence of excess DNA substrate and in
the absence of a protein trap (Fig. 1D), indicating that some
DNA unwinding activity is retained under conditions that dis-
favor binding of multiple molecules to the same substrate mol-
ecule. However, the low activity may be due to a monomeric
form of NS3 or a low amount of oligomeric NS3. Further work
is required to discern between these possibilities.
The protease domain clearly has a major role in defining the
quaternary structure of NS3. Recent work indicates that this
role extends to the enzymatic activities of NS3. A report from
Frick et al. (33) indicates that NS3 unwinds RNA better than
NS3h. We have previously reported results from single turn-
over studies that showed NS3h (500 nM) was capable of
unwinding a 30-bp DNA substrate (2 nM) poorly, yielding only
10%product (35), which is consistentwith the extensive stud-
ies reported earlier by Levin et al. (40). In contrast to NS3h,
full-length NS3 exhibits much higher processivity, unwinding
80% of the 30-bp substrate under identical conditions. We
previously reported that under the conditions employed here,
NS3 is capable of binding to the ssDNA and double-stranded
DNA portions of the 15-nt/30-bp substrate. The ability of NS3
to “coat” the entire DNA substrate may play an important role
in the processive DNA unwinding. NS3h does not bind tightly
to the duplex region of the substrate under conditions reported
here,5 which may help to explain the low activity of NS3h rela-
tive to NS3.
In conclusion, under conditions in which NS3 concentration
exceeds the substrate concentration, NS3 unwinds DNA in a
fast and relatively processive manner. However, when DNA
substrate greatly exceeds the enzyme concentration, NS3
unwinding activity is greatly reduced. The reason for this dif-
ference appears to be directly related to fact that NS3 exists as
an oligomer in solution under conditions studied here and that
the substrate must be bound by multiple protein units of the
oligomer for optimal unwinding to occur.
Acknowledgments—We thank Qixin Wang and Samuel Mackintosh
for helpful discussions and Piero Bianco for the generous gift of E. coli
SSB.
REFERENCES
1. Delagoutte, E., and von Hippel, P. H. (2002) Q. Rev. Biophys. 35,
431–478
2. Soultanas, P., and Wigley, D. B. (2001) Trends Biochem. Sci. 26, 47–54
3. Singleton, M. R., Dillingham, M. S., and Wigley, D. B. (2007) Annu. Rev.
Biochem. 76, 23–50
4. Patel, S. S., and Donmez, I. (2006) J. Biol. Chem. 281, 18265–18268
5. Ellis, N. A. (1997) Curr. Opin. Genet. Dev. 7, 354–363
6. Dong, F., Gogol, E. P., and von Hippel, P. H. (1995) J. Biol. Chem. 270,
7462–7473
7. Patel, S. S., and Picha, K. M. (2000) Annu. Rev. Biochem. 69, 651–697
8. Nanduri, B., Byrd, A. K., Eoff, R. L., Tackett, A. J., and Raney, K. D. (2002)
Proc. Natl. Acad. Sci. U. S. A. 99, 14722–14727
9. Byrd, A. K., and Raney, K. D. (2005) Biochemistry 44, 12990–12997
5 K. Raney and B. Sikora, unpublished observations.
NS3 Exists as an Oligomer in Vitro
11524 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 283 • NUMBER 17 • APRIL 25, 2008
10. Sikora, B., Eoff, R. L., Matson, S.W., and Raney, K. D. (2006) J. Biol. Chem.
281, 36110–36116
11. McHutchison, J. G. (2004) Am. J. Manag. Care 10, S21–S29
12. Pearlman, B. L. (2004) South. Med. J. 97, 364–373
13. Choo, Q. L., Weiner, A. J., Overby, L. R., Kuo, G., Houghton, M., and
Bradley, D. W. (1990) Br. Med. Bull. 46, 423–441
14. Bartenschlager, R., and Lohmann, V. (2000) J. Gen. Virol. 81, 1631–1648
15. Kim, D. W., Gwack, Y., Han, J. H., and Choe, J. (1995) Biochem. Biophys.
Res. Commun. 215, 160–166
16. Frick, D. N. (2003) Drug News Perspect. 16, 355–362
17. Suzich, J. A., Tamura, J. K., Palmer-Hill, F., Warrener, P., Grakoui, A.,
Rice, C. M., Feinstone, S. M., and Collett, M. S. (1993) J. Virol. 67,
6152–6158
18. Kang, L.W., Cho,H. S., Cha, S. S., Chung, K.M., Back, S. H., Jang, S. K., and
Oh, B. H. (1998) Acta Crystallogr. D Biol. Crystallogr. 54, 121–123
19. Yao, N., Hesson, T., Cable, M., Hong, Z., Kwong, A. D., Le, H. V., and
Weber, P. C. (1997) Nat. Struct. Biol. 4, 463–467
20. Yao, N., Reichert, P., Taremi, S. S., Prosise,W.W., andWeber, P. C. (1999)
Structure 7, 1353–1363
21. Gwack, Y., Kim, D. W., Han, J. H., and Choe, J. (1996) Biochem. Biophys.
Res. Commun. 225, 654–659
22. Gwack, Y., Kim, D.W., Han, J. H., and Choe, J. (1997) Eur. J. Biochem. 250,
47–54
23. Tai, C. L., Chi, W. K., Chen, D. S., and Hwang, L. H. (1996) J. Virol. 70,
8477–8484
24. Kim, J. L., Morgenstern, K. A., Griffith, J. P., Dwyer,M. D., Thomson, J. A.,
Murcko, M. A., Lin, C., and Caron, P. R. (1998) Structure 6, 89–100
25. Porter, D. J., Short, S. A., Hanlon, M. H., Preugschat, F., Wilson, J. E.,
Willard, D. H., Jr., and Consler, T. G. (1998) J. Biol. Chem. 273,
18906–18914
26. Tackett, A. J., Chen, Y., Cameron, C. E., and Raney, K. D. (2005) J. Biol.
Chem. 280, 10797–10806
27. Serebrov, V., and Pyle, A. M. (2004) Nature 430, 476–480
28. Dumont, S., Cheng, W., Serebrov, V., Beran, R. K., Tinoco, I., Jr., Pyle,
A. M., and Bustamante, C. (2006) Nature 439, 105–108
29. Levin, M. K., Wang, Y. H., and Patel, S. S. (2004) J. Biol. Chem. 279,
26005–26012
30. Byrd, A. K., and Raney, K. D. (2004) Nat. Struct. Mol. Biol. 11, 531–538
31. Byrd, A. K., and Raney, K. D. (2006) Nucleic Acids Res. 34, 3020–3029
32. Eoff, R. L., Spurling, T. L., and Raney, K. D. (2005) Biochemistry 44,
666–674
33. Frick, D. N., Rypma, R. S., Lam, A.M., andGu, B. (2004) J. Biol. Chem. 279,
1269–1280
34. Khu, Y. L., Koh, E., Lim, S. P., Tan, Y. H., Brenner, S., Lim, S. G., Hong,
W. J., and Goh, P. Y. (2001) J. Virol. 75, 205–214
35. Mackintosh, S. G., Lu, J. Z., Jordan, J. B., Harrison, M. K., Sikora, B.,
Sharma, S. D., Cameron, C. E., Raney, K. D., and Sakon, J. (2006) J. Biol.
Chem. 281, 3528–3535
36. Runyon, G. T., and Lohman, T. M. (1993) Biochemistry 32, 4128–4138
37. Myong, S., Bruno, M. M., Pyle, A. M., and Ha, T. (2007) Science 317,
513–516
38. Beran, R. K., Bruno, M. M., Bowers, H. A., Jankowsky, E., and Pyle, A. M.
(2006) J. Mol. Biol. 358, 974–982
39. Pang, P. S., Jankowsky, E., Planet, P. J., and Pyle, A. M. (2002) EMBO J. 21,
1168–1176
40. Levin, M. K., and Patel, S. S. (1999) J. Biol. Chem. 274, 31839–31846
41. Velankar, S. S., Soultanas, P., Dillingham, M. S., Subramanya, H. S., and
Wigley, D. B. (1999) Cell 97, 75–84
42. Dillingham,M. S.,Wigley, D. B., andWebb,M. R. (2002) Biochemistry 41,
643–651
43. Bujalowski, W., Klonowska, M. M., and Jezewska, M. J. (1994) J. Biol.
Chem. 269, 31350–31358
44. Maluf, N. K., Fischer, C. J., and Lohman, T. M. (2003) J. Mol. Biol. 325,
913–935
45. Cheng, W., Hsieh, J., Brendza, K. M., and Lohman, T. M. (2001) J. Mol.
Biol. 310, 327–350
46. Fischer, C. J., Maluf, N. K., and Lohman, T. M. (2004) J. Mol. Biol. 344,
1287–1309
47. Rajagopal, V., and Patel, S. S. (2008) J. Mol. Biol. 376, 69–79
48. Dimitrova,M., Imbert, I., Kieny,M. P., and Schuster, C. (2003) J. Virol. 77,
5401–5414
49. Ishido, S., Fujita, T., andHotta, H. (1998)Biochem. Biophys. Res. Commun.
244, 35–40
50. Piccininni, S., Varaklioti, A., Nardelli, M., Dave, B., Raney, K. D., and
McCarthy, J. E. (2002) J. Biol. Chem. 277, 45670–45679
51. Jennings, T. A., Chen, Y., Sikora, D., Harrison,M. K., Sikora, B., Huang, L.,
Jankowsky, E., Fairman, M. E., Cameron, C. E., and Raney, K. D. (2008)
Biochemistry 47, 1126–1135
52. Zhang, C., Cai, Z., Kim, Y. C., Kumar, R., Yuan, F., Shi, P. Y., Kao, C., and
Luo, G. (2005) J. Virol. 79, 8687–8697
53. Quinkert, D., Bartenschlager, R., and Lohmann, V. (2005) J. Virol. 79,
13594–13605
NS3 Exists as an Oligomer in Vitro
APRIL 25, 2008 • VOLUME 283 • NUMBER 17 JOURNAL OF BIOLOGICAL CHEMISTRY 11525
